0
Letters |

Vitamin D Supplementation for Cardiovascular Disease Prevention—Reply

Sue A. Shapses, PhD; JoAnn E. Manson, MD, DrPH
JAMA. 2011;306(14):1546-1548. doi:10.1001/jama.2011.1466.
Text Size: A A A
Published online

Extract

In Reply: Our Commentary critically appraised the evidence that vitamin D prevents cardiovascular disease and diabetes, highlighting that the available research is inconsistent and does not yet prove a cause-and-effect relationship. This is also the conclusion reached by the Agency for Healthcare Research and Quality,1 the IOM,2 and a meta-analysis of 51 trials.3 The meta-analysis, which documented the absence of supportive trial evidence, was cited by Holick et al4 in the Endocrine Society Clinical Practice Guideline, which stated: “We do not recommend prescribing vitamin D supplementation beyond recommended daily needs for the purpose of preventing cardiovascular disease or death or improving quality of life.” Thus, it is puzzling why Dr O’Keefe and colleagues now suggest that research demonstrates cardiovascular benefits of vitamin D. Association does not prove causation in observational studies, and confounding cannot be excluded as an explanation for correlations.2 Large randomized trials designed to test hypotheses that benefits of high-dose vitamin D outweigh risks are important.

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

October 12, 2011
James H. O’Keefe, MD; Carl J. Lavie, MD; Michael F. Holick, PhD, MD
JAMA. 2011;306(14):1546-1548. doi:10.1001/jama.2011.1465.
CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs